Analgesic and side effects of intravenous recombinant Phα1β.

Flavia Karine RigoMateus Fortes RossatoVanessa BorgesJuliana Figueira da SilvaElizete Maria Rita PereiraRicardo Andrez Machado de ÁvilaGabriela TrevisanDuana Carvalho Dos SantosDanuza Montijo DinizMarco Aurélio Romano SilvaCélio José de CastroThiago Mattar CunhaJuliano FerreiraMarcus Vinicius Gomez

Published in: The journal of venomous animals and toxins including tropical diseases (2020)

Our data suggest that intravenous administration of recombinant Phα1β may be feasible for drug-induced analgesia, without causing any severe side effects.

Keyphrases

drug induced
liver injury
high dose
cell free
pain management
adverse drug
neuropathic pain
big data
ultrasound guided
low dose
early onset
data analysis
artificial intelligence
spinal cord injury